Evidence map›Paper›PMID 35500228›Full record

ArticleJournal of the American Chemical Society2022

Uncovering the Key Role of Distortion in Bioorthogonal Tetrazine Tools That Defy the Reactivity/Stability Trade-Off.

Dennis Svatunek, Martin Wilkovitsch, Lea Hartmann, K N Houk, Hannes Mikula

Open access · hybridAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 100 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Click-to-Release Reactions for Tertiary Amines and Pyridines.Journal of the American Chemical Society · 2026
    Article
  7. Tetrazine-Inorganic chemistry frontiers · 2026
    Article
  8. Protein Modification via Bioorthogonal HS-BCN Ligation.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  9. Review
  10. Biocompatible Chemistry: A Plug-and-Play Toolbox for Chemical Biology Research.Chembiochem : a European journal of chemical biology · 2025
    Review
  11. Chemical Tagging ofJournal of the American Chemical Society · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Dennis SvatunekInstitute of Applied Synthetic Chemistry, TU Wien 1060 Vienna, Austria.ORCID 0000-0003-1101-2376
Martin WilkovitschInstitute of Applied Synthetic Chemistry, TU Wien 1060 Vienna, Austria.
Lea HartmannInstitute of Applied Synthetic Chemistry, TU Wien 1060 Vienna, Austria.
K N HoukDepartment of Chemistry and Biochemistry, University of California, Los Angeles, Los Angeles 90095, United States.ORCID 0000-0002-8387-5261
Hannes MikulaInstitute of Applied Synthetic Chemistry, TU Wien 1060 Vienna, Austria.ORCID 0000-0002-9218-9722
TU Wien · ATUniversity of California, Los Angeles · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The tetrazine/

Indexed as

Heterocyclic CompoundsCycloaddition ReactionElectronsKineticsHeterocyclic Compounds

Identifiers

PMID35500228
PMCPMC9100665
OpenAlexW4225328494

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.